sci2sci develops software that connects and verifies fragmented enterprise data, providing traceable information for AI and regulatory workflows in biopharma and other regulated industries.
sci2sci has raised €1.2M across 1 funding round from 4 investors, most recently a Pre-Seed round in Sep 2026. Based in Berlin, Germany; active in Software. Data as of 9 Sept 2026.
Timing: too soon vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2026-09-08 | Pre-Seed | €1.2M |
| Heliad,IBB Ventures,Robin Capital,Superangels |
| View deal → |
